Cardiac Failure Review

Scope & Guideline

Fostering discussions that shape cardiac care.

Introduction

Immerse yourself in the scholarly insights of Cardiac Failure Review with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2057-7540
PublisherRADCLIFFE CARDIOLOGY
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2019 to 2024
AbbreviationCARD FAIL REV / Card. Fail. Rev.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUNIT F, BOURNE END BUSINESS PARK, BOURNE END, BUCKS SL8 5AS, ENGLAND

Aims and Scopes

The journal 'Cardiac Failure Review' is dedicated to advancing the understanding and management of heart failure through a comprehensive examination of its various aspects. The focus encompasses clinical, epidemiological, and therapeutic dimensions of heart failure, with an emphasis on innovative treatment strategies, diagnostic advancements, and patient-centered care.
  1. Heart Failure Management and Therapy:
    The journal emphasizes the latest developments in the management and therapeutic approaches to heart failure, including pharmacological treatments, device therapies, and patient education.
  2. Diagnostic Imaging and Biomarkers:
    A significant focus is placed on advancements in diagnostic imaging techniques and the identification of biomarkers that aid in the early detection, prognosis, and management of heart failure.
  3. Epidemiology and Public Health:
    Research published in the journal often addresses the epidemiological aspects of heart failure, including its global burden, demographic variations, and the impact of socioeconomic factors on patient outcomes.
  4. Multidisciplinary Approaches to Heart Failure Care:
    The journal highlights the importance of a multidisciplinary approach in heart failure management, integrating insights from cardiology, nursing, pharmacy, and public health.
  5. Emerging Therapies and Technologies:
    Innovations in treatment modalities, such as telemedicine and remote monitoring technologies, are explored to enhance patient management and outcomes.
The 'Cardiac Failure Review' has reflected emerging trends in heart failure research, highlighting new areas of focus that are gaining traction among researchers and clinicians. These trends indicate a shift towards more personalized, innovative, and comprehensive care models for heart failure patients.
  1. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Research on HFpEF has surged, focusing on its unique challenges, treatment strategies, and the importance of this condition in the broader context of heart failure management.
  2. Telemedicine and Remote Monitoring:
    The integration of telemedicine and remote patient monitoring technologies has become increasingly prominent, particularly in light of the COVID-19 pandemic, emphasizing the need for innovative care solutions.
  3. Diversity and Health Disparities:
    There is a growing emphasis on understanding and addressing health disparities in heart failure care, particularly among minority populations, highlighting the importance of equitable healthcare access.
  4. Biomarkers and Personalized Medicine:
    The exploration of biomarkers for early detection and personalized treatment strategies is on the rise, reflecting a shift towards tailored therapy based on individual patient profiles.
  5. Multimodality Imaging:
    The use of multimodality imaging techniques to enhance diagnosis and treatment planning in heart failure is emerging as a critical theme, showcasing advancements in imaging technologies.

Declining or Waning

Over recent years, certain themes within the 'Cardiac Failure Review' have shown a decline in publication frequency, suggesting a shift in focus or a saturation of research in those areas. This decline may reflect evolving priorities in heart failure research or advancements that have rendered some topics less critical.
  1. Traditional Pharmacotherapy:
    While traditional pharmacotherapy for heart failure remains important, there has been a noticeable decline in articles focused on older classes of medications, as newer therapies and treatment strategies gain prominence.
  2. Basic Pathophysiological Studies:
    Research centered on basic pathophysiological mechanisms of heart failure has decreased, possibly due to a growing emphasis on clinical applications and translational research.
  3. Generalized Management Guidelines:
    Publications that reiterate general heart failure management guidelines without new insights or data have diminished, as the field moves towards more personalized and patient-specific treatment approaches.

Similar Journals

Revista Portuguesa de Cardiologia

Transforming cardiovascular medicine with cutting-edge research.
Publisher: ELSEVIER ESPANA SLUISSN: 0870-2551Frequency: 12 issues/year

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

Korean Circulation Journal

Fostering Evidence-Based Practices in Cardiovascular Care.
Publisher: KOREAN SOC CARDIOLOGYISSN: 1738-5520Frequency: 12 issues/year

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

Frontiers in Cardiovascular Medicine

Connecting Global Insights for Heart Health Advancement.
Publisher: FRONTIERS MEDIA SAISSN: 2297-055XFrequency: 1 issue/year

Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

Circulation-Heart Failure

Elevating the standard of cardiovascular medicine.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1941-3289Frequency: 12 issues/year

Welcome to Circulation-Heart Failure, a leading peer-reviewed journal published by Lippincott Williams & Wilkins dedicated to advancing the field of cardiac biology and clinical cardiology. With an impressive impact factor and ranked in the Q1 category both in Cardiology and Cardiovascular Medicine and in Medicine (miscellaneous), this journal stands out as a vital resource for researchers, clinicians, and students. Since its inception in 2008, Circulation-Heart Failure has been at the forefront of disseminating innovative research, expert reviews, and clinical practices related to heart failure and cardiovascular health. The journal, housed in the United States, is committed to fostering a deeper understanding of heart failure management, offering regular issues that converge comprehensive studies, cutting-edge clinical insights, and the latest advancements in therapeutic strategies. Engage with the latest findings and contribute to the dialogue in a journal recognized for its rigorous standards and significant contributions to the cardiology community.

KARDIOLOGIYA

Fostering Collaboration for Heart Health Advancements
Publisher: RUSSIAN HEART FAILURE SOCISSN: 0022-9040Frequency: 12 issues/year

KARDIOLOGIYA is a renowned academic journal in the field of cardiology, published by the Russian Heart Failure Society. Since its inception in 1961, this journal has been dedicated to disseminating cutting-edge research in cardiovascular medicine, contributing to the global understanding of heart-related diseases and their management. With a significant publication history that spans over six decades, KARDIOLOGIYA provides a platform for both established researchers and emerging scholars to publish their findings. Despite its current Q4 category ranking in the 2023 Cardiology and Cardiovascular Medicine category, the journal plays a crucial role in promoting regional insights and advancements in cardiology, while striving towards higher visibility and impact within the academic community. While not an open-access journal, the journal is accessible to institutions and professionals in the Russian Federation and beyond, fostering collaboration and knowledge sharing among healthcare professionals. With a Scopus rank of #259 among 387 journals, it is well-positioned to enhance discourse in the field and support the development of innovative approaches to cardiovascular care.

Arquivos Brasileiros de Cardiologia

Unveiling new horizons in cardiology through open access.
Publisher: ARQUIVOS BRASILEIROS CARDIOLOGIAISSN: 0066-782XFrequency: 12 issues/year

Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.

JACC-Cardiovascular Imaging

Pioneering Insights in Diagnostic Imaging
Publisher: ELSEVIER SCIENCE INCISSN: 1936-878XFrequency: 12 issues/year

JACC-Cardiovascular Imaging, published by Elsevier Science Inc, is a premier journal that focuses on the rapidly evolving field of cardiovascular imaging, providing a vital platform for the dissemination of high-quality research and clinical studies. With an impressive impact factor and ranking within the top tier of cardiology and radiology specialties, the journal is recognized for its commitment to advancing knowledge in diagnostic imaging techniques, including echocardiography, MRI, and CT in cardiovascular contexts. Since its inception in 2008 and converging through 2024, JACC-Cardiovascular Imaging has maintained a distinguished position, currently ranking Q1 both in Cardiology and Cardiovascular Medicine as well as in Radiology, Nuclear Medicine and Imaging. This ensures its relevance and influence, as evidenced by its Scopus rankings—ranked #2 in Radiology and #8 in Cardiology, placing it in the top echelons of scholarly output. Although it does not offer open access, the journal's content is crucial for researchers, clinicians, and students who seek to remain at the forefront of cardiovascular imaging advancements.

ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES

Advancing the Art of Cardiovascular Imaging
Publisher: WILEYISSN: 0742-2822Frequency: 12 issues/year

ECHOCARDIOGRAPHY: A Journal of Cardiovascular Ultrasound and Allied Techniques is a premier scholarly publication committed to advancing the field of cardiovascular imaging through the dissemination of high-quality research and clinical studies. Published by Wiley, this journal has been a vital resource since its inception in 1984, aiming to bridge the gap between ultrasound techniques and clinical practice over its converged years extending to 2024. With an ISSN of 0742-2822 and an E-ISSN of 1540-8175, the journal is indexed in notable databases and holds a respectable standing in its field, reflected in its Q3 rankings in Cardiovascular Medicine, Miscellaneous Medicine, and Radiology for 2023. Though currently not open access, the journal strives to provide valuable insights and innovative techniques to researchers, professionals, and students alike, fostering a deeper understanding of echocardiography and its impact on patient care. Located in the United States, the journal continues to serve as a cornerstone for contemporary cardiovascular research and education, ensuring that the latest advancements and practices are readily accessible to the medical community.

ESC Heart Failure

Advancing heart health through groundbreaking research.
Publisher: WILEY PERIODICALS, INCISSN: 2055-5822Frequency: 6 issues/year

ESC Heart Failure is a premier academic journal dedicated to the field of cardiology, specifically focusing on heart failure and its management. Published by WILEY PERIODICALS, INC, this esteemed journal has been an open access publication since 2014, making cutting-edge research readily accessible to a global audience. With its impressive impact factor and recent classification as a Q1 journal in Cardiology and Cardiovascular Medicine for 2023, ESC Heart Failure stands out as a leading resource with a Scopus ranking of #68 out of 387 in its field, placing it in the 82nd percentile. The journal aims to disseminate vital research findings, reviews, and clinical insights that advance the understanding and treatment of heart failure, thereby supporting healthcare professionals, researchers, and students in enhancing patient care. Its commitment to quality and relevance makes ESC Heart Failure an essential publication for anyone involved in cardiovascular medicine.

Cardiology Journal

Unleashing insights for better heart health.
Publisher: VIA MEDICAISSN: 1897-5593Frequency: 6 issues/year

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.